Rare disease research operates under conditions of extreme complexity. These pressures are driving new approaches to evidence ...

Dr Gen Li is a pharmaceutical industry leader with a passion to improve patients’ lives. Prior to founding Phesi in 2007, Dr ...

Researchers at the University of Houston have identified epithelial stress signalling as a key driver of Crohn's disease and ...

VIB-VUB researchers have developed a patient-relevant lung adenocarcinoma model combined with SEPARATE-Seq technology to ...

Researchers at ETH Zurich have developed an automated system that uses infrared imaging and artificial intelligence to assess ...

Dr Aaron Wenger reveals how improvements in long-read sequencing technology is enabling the elucidation of complex disease ...

For years, AI drug discovery has been judged on benchmark performance. Now, a set of studies shows what happens when those ...

Madison have reported a new approach to forming carbon-nitrogen bonds, a critical step in the synthesis of amines widely used ...

A novel microphysiological system using ovarian follicles enables physiologically relevant three-dimensional angiogenesis ...

Dr Christopher Saunter is the co-founder and Chief Technology Officer of Magnitude Biosciences, a UK-based contract research ...

Aaron Wenger is a senior director and principal scientist at Pacific Biosciences, where he oversees the long-read sequencing ...

All Opinion and interviews articles in Drug Target Review ...